R&D Solutions


Develop innovative, targeted drugs, and ensure compliance and safety

Get started

We help you apply reliable science to develop innovative, targeted drugs and ensure compliance and safety

Developing effective, safe and affordable drugs today requires targeted and data-driven R&D. Managing compliance and safety risks as available data increases requires scalable and streamlined adverse event monitoring.

R&D Solutions for Drug Discovery & Development

Realize the potential of data-driven drug discovery and development with solutions that help you increase research efficiency and ensure a thriving R&D pipeline.

Learn more about Drug Discovery & Development solutions

R&D Solutions for Pharmacovigilance

Achieve pharmacovigilance with less pain with solutions that help you identify critical patient safety signals and automate the process of capturing and managing adverse drug reaction and safety information.
Learn more about Pharmacovigilance solutions

Pharma R&D professionals working in drug discovery | Eslevier

Our customers

Thousands of researchers and other pharma R&D professionals working in drug discovery, development and pharmacovigilance rely on our solutions. We serve:

  • 47 of the top 50 biopharmaceutical companies named by PharmExec
  • 22 of the 25 world's largest pharmaceutical companies ranked by Forbes
  • All 10 of the most innovative pharmaceutical companies, as recognized at the 2016 JP Morgan Healthcare conference

Translate data into insightful results and decisions

Elsevier’s solutions provide analytics and technology capabilities together with data to help you make reliable data-driven decisions in Life Sciences and Pharmaceutical sectors.

Transforming the way new therapies reach the world

Data-driven partnerships

Data-driven evaluation - R&D Solutions | Elsevier

Pharmaceutical companies rely heavily on data analysis to advance drug research, but this data-driven approach also increasingly applies to the search for collaborators.

Read the white paper

A big picture for Pharma

Drug attrition in check - R&D Solutions | Elsevier

Systems biology and chemistry data has incredible potential for reducing drug development costs and attrition rates. This new white paper examines the issue in detail.

See the white paper

Balancing in-house and outsourced monitoring

A balanced approach to literature monitoring - R&D Solutions | Elsevier

Combining outsourced literature management with an in-house solution can help companies overcome search challenges by improving oversight, increasing efficiency and providing greater flexibility in managing workload.

Read the white paper

Improving the accuracy of signal detection

Signal detection in spontaneous reporting can be challenging - R&D Solutions | Elsevier

Pharmacovigilance ensures the correct use of a drug, safeguarding it as a meaningful treatment option. But working with spontaneous adverse event reporting systems poses challenges. Find out how to overcome them.

Read the white paper

Elsevier's R&D Solutions for Pharma & Life Sciences


Drive successful early drug discovery by providing chemists the shortest path to relevant literature, patent information, valid compound properties, and experimental procedures.

Learn more about Reaxys

Reaxys Medicinal Chemistry

Achieve more efficient hit identification and lead optimization by providing chemists the shortest path to normalized compound–target affinity data and comprehensive pharmacokinetic, efficacy, toxicity, safety and metabolic profiles.
Learn more about Reaxys Medicinal Chemistry


Uncover drug-disease relationships and drug-drug interactions by increasing the discovery of biomedical evidence and providing comprehensive relevant, up-to-date biomedical information.

Learn more about Embase


Make more informed drug development decisions on safety and efficacy, risk assessments and mitigation, and study designs by providing researchers with searchable FDA/EMA drug approval documents and comparative drug safety data.
Learn more about PharmaPendium


Promote efficiency and organizational compliance by centralizing the discovery of adverse event information and automating information monitoring and triage in a scalable environment.

Learn more about QUOSA

Pathway Studio

Streamline target and biomarker identification and drug repurposing by providing biological researchers with greater insight into the mechanisms of disease and facilitating the interpretation of experimental data.
Learn more about Pathway Studio

Professional Services

Drive innovative pharmaceutical research by resolving challenges with data quality and integration and making data easier for researchers to compare, analyze, interpret and share.

Learn more about Professional Services


Explore award-winning semantic analytics software that combines machine learning with an ontology-led approach.  SciBite's core technologies help customers maximise the value from their data by helping them model, semantically annotate and enrich the data,  transforming it into rich, machine-readable clean and contextualised data free from ambiguities.

Learn more about SciBite


Help researchers understand the entire breadth of research surrounding a disease by helping them more effectively and efficiently search authoritative, full-text scientific, technical and health content.

Learn more about ScienceDirect


Detect trends, find partnerships and identify experts to stay on the cutting edge of research through the world’s largest abstract and citation database of peer-reviewed literature, including tools to track, analyze and visualize research.
Learn more about Scopus

How we help

Elsevier’s R&D Solutions integrate data, analytics and technology to help you make data-driven drug discovery and development decisions and streamline literature monitoring for pharmacovigilance. Our pharma & life sciences solutions — Reaxys, ScienceDirect , Scopus, Embase, QUOSA, PharmaPendium and Pathway Studio — are all backed by Elsevier's unique and deep expertise in data, science and technology.